HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Casty Selected Research

sibenadet (Viozan)

1/2003Conclusion. Lessons from the novel D2 dopamine receptor, beta2-adrenoceptor agonist, Viozan: chronic obstructive pulmonary disease and drug development implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Casty Research Topics

Disease

1Chronic Obstructive Pulmonary Disease (COPD)
01/2003

Drug/Important Bio-Agent (IBA)

1sibenadet (Viozan)IBA
01/2003
1Dopamine (Intropin)FDA LinkGeneric
01/2003
1Pharmaceutical PreparationsIBA
01/2003
1Dopamine Receptors (Dopamine Receptor)IBA
01/2003

Therapy/Procedure

1Therapeutics
01/2003